Revenue Summary of Wai Chun Bio-Technology Limited

Wai Chun Bio-Technology Limited's latest annual revenue in 2022 was 773.65 Million HKD , up 15.22% from previous year.
Wai Chun Bio-Technology Limited's latest quarterly revenue in 2023 Q4 was 190.33 Million HKD , up 100.0% from previous quarter.
Wai Chun Bio-Technology Limited reported a annual revenue of 671.46 Million HKD in annual revenue 2021, up 18.31% from previous year.
Wai Chun Bio-Technology Limited reported a annual revenue of 567.55 Million HKD in annual revenue 2020, down -2.02% from previous year.
Wai Chun Bio-Technology Limited reported a quarterly revenue of 95.16 Million HKD for 2023 Q3, down -74.18% from previous quarter.
Wai Chun Bio-Technology Limited reported a quarterly revenue of 368.57 Million HKD for 2023 Q2, up 100.0% from previous quarter.

Annual Revenue Chart of Wai Chun Bio-Technology Limited (2022 - 2004)

Historical Annual Revenue of Wai Chun Bio-Technology Limited (2022 - 2004)

Year	Revenue	Revenue Growth
2022	773.65 Million HKD	15.22%
2021	671.46 Million HKD	18.31%
2020	567.55 Million HKD	-2.02%
2019	579.23 Million HKD	20.46%
2018	480.85 Million HKD	-6.11%
2017	512.13 Million HKD	10.18%
2016	464.8 Million HKD	23.35%
2015	376.8 Million HKD	-4.39%
2014	394.11 Million HKD	5.5%
2013	373.58 Million HKD	-3.39%
2012	386.67 Million HKD	6.73%
2011	362.31 Million HKD	27.52%
2010	284.12 Million HKD	2062.81%
2009	13.13 Million HKD	-84.07%
2008	82.48 Million HKD	21.15%
2007	68.08 Million HKD	-48.59%
2006	132.41 Million HKD	-55.51%
2005	297.63 Million HKD	14.71%
2004	259.47 Million HKD	0.0%

Year	Revenue	Revenue Growth
2023 Q4	190.33 Million HKD	100.0%
2023 Q3	95.16 Million HKD	-74.18%
2023 Q2	368.57 Million HKD	100.0%
2023 Q1	184.28 Million HKD	-54.51%
2022 Q3	202.54 Million HKD	-56.35%
2022 Q4	405.08 Million HKD	100.0%
2022 FY	773.65 Million HKD	15.22%
2022 Q2	463.95 Million HKD	0.0%
2021 Q3	103.75 Million HKD	-63.96%
2021 Q4	207.5 Million HKD	100.0%
2021 FY	671.46 Million HKD	18.31%
2021 Q1	143.93 Million HKD	-55.08%
2021 Q2	287.87 Million HKD	100.0%
2020 Q3	160.22 Million HKD	-35.16%
2020 Q1	123.55 Million HKD	-60.14%
2020 Q4	320.44 Million HKD	100.0%
2020 Q2	247.1 Million HKD	100.0%
2020 FY	567.55 Million HKD	-2.02%
2019 Q2	269.29 Million HKD	100.0%
2019 Q3	154.96 Million HKD	-42.45%
2019 Q4	309.93 Million HKD	100.0%
2019 Q1	134.64 Million HKD	13.22%
2019 FY	579.23 Million HKD	20.46%
2018 Q1	121.5 Million HKD	-14.8%
2018 Q3	118.92 Million HKD	-2.12%
2018 FY	480.85 Million HKD	-6.11%
2018 Q4	118.92 Million HKD	0.0%
2018 Q2	121.5 Million HKD	0.0%
2017 Q4	142.6 Million HKD	0.0%
2017 Q3	142.6 Million HKD	25.69%
2017 Q2	113.46 Million HKD	0.0%
2017 FY	512.13 Million HKD	10.18%
2017 Q1	113.46 Million HKD	-16.78%
2016 FY	464.8 Million HKD	23.35%
2016 Q3	136.34 Million HKD	41.93%
2016 Q2	96.06 Million HKD	0.0%
2016 Q1	96.06 Million HKD	-9.47%
2016 Q4	136.34 Million HKD	0.0%
2015 Q4	106.11 Million HKD	0.0%
2015 FY	376.8 Million HKD	-4.39%
2015 Q3	106.11 Million HKD	28.94%
2015 Q2	82.29 Million HKD	0.0%
2015 Q1	82.29 Million HKD	-28.97%
2014 Q4	115.85 Million HKD	0.0%
2014 FY	394.11 Million HKD	5.5%
2014 Q3	115.85 Million HKD	42.67%
2014 Q2	81.2 Million HKD	0.0%
2014 Q1	81.2 Million HKD	-17.09%
2013 FY	373.58 Million HKD	-3.39%
2013 Q3	97.94 Million HKD	10.24%
2013 Q4	97.94 Million HKD	0.0%
2013 Q1	88.84 Million HKD	-4.87%
2013 Q2	88.84 Million HKD	0.0%
2012 Q2	96.66 Million HKD	0.0%
2012 Q3	96.66 Million HKD	0.0%
2012 Q1	96.66 Million HKD	0.0%
2012 FY	386.67 Million HKD	6.73%
2012 Q4	93.39 Million HKD	-3.39%
2011 Q4	96.66 Million HKD	6.73%
2011 FY	362.31 Million HKD	27.52%
2011 Q1	90.57 Million HKD	0.0%
2011 Q2	90.57 Million HKD	0.0%
2011 Q3	90.57 Million HKD	0.0%
2010 Q3	71.03 Million HKD	0.0%
2010 FY	284.12 Million HKD	2062.81%
2010 Q4	90.57 Million HKD	27.52%
2010 Q2	71.03 Million HKD	0.0%
2010 Q1	71.03 Million HKD	0.0%
2009 FY	13.13 Million HKD	-84.07%
2009 Q4	71.03 Million HKD	2062.81%
2009 Q3	3.28 Million HKD	0.0%
2009 Q2	3.28 Million HKD	0.0%
2009 Q1	3.28 Million HKD	0.0%
2008 Q1	20.62 Million HKD	0.0%
2008 FY	82.48 Million HKD	21.15%
2008 Q4	3.28 Million HKD	-84.07%
2008 Q3	20.62 Million HKD	0.0%
2008 Q2	20.62 Million HKD	0.0%
2007 Q2	17.02 Million HKD	0.0%
2007 Q1	17.02 Million HKD	0.0%
2007 FY	68.08 Million HKD	-48.59%
2007 Q3	17.02 Million HKD	0.0%
2007 Q4	20.62 Million HKD	21.15%
2006 Q1	33.1 Million HKD	0.0%
2006 Q2	33.1 Million HKD	0.0%
2006 Q3	33.1 Million HKD	0.0%
2006 Q4	17.02 Million HKD	-48.59%
2006 FY	132.41 Million HKD	-55.51%
2005 Q2	74.4 Million HKD	0.0%
2005 Q1	74.4 Million HKD	0.0%
2005 FY	297.63 Million HKD	14.71%
2005 Q4	33.1 Million HKD	-55.51%
2005 Q3	74.4 Million HKD	0.0%
2004 FY	259.47 Million HKD	0.0%
2004 Q2	64.86 Million HKD	0.0%
2004 Q1	64.86 Million HKD	0.0%
2004 Q4	74.4 Million HKD	14.71%
2004 Q3	64.86 Million HKD	0.0%
2003 Q4	64.86 Million HKD	0.0%

Peer Revenue Comparison of Wai Chun Bio-Technology Limited

Name	Revenue	Revenue Difference
Lee & Man Chemical Company Limited	4.05 Billion HKD	80.9%

Global Stocks Search

Wai Chun Bio-Technology Limited (0660.HK)

Revenue Summary of Wai Chun Bio-Technology Limited

Annual Revenue Chart of Wai Chun Bio-Technology Limited (2022 - 2004)

Historical Annual Revenue of Wai Chun Bio-Technology Limited (2022 - 2004)

Peer Revenue Comparison of Wai Chun Bio-Technology Limited